-
1
المؤلفون: Erik De Clercq, Guangdi Li, Yali Wang
المصدر: Acta Pharmaceutica Sinica B. 12:1567-1590
مصطلحات موضوعية: NNRTI, Oncology, HAART, Dapivirine, IC50, half maximal inhibitory concentration, law.invention, F, bioavailability, RPV, rilpivirine, MSM, men who have sex with men, chemistry.chemical_compound, NNRTI, non-nucleoside reverse transcriptase inhibitor, Randomized controlled trial, law, t1/2, elimination half-life, Doravirine, CC50, the 50% cytotoxic concentration, EFV, efavirenz, 3TC, (−)-2′,3′-dideoxy-3′-thiacytidine (common name, lamivudine), General Pharmacology, Toxicology and Pharmaceutics, ABC, abacavir, ESV, elsulfavirine, FDA, US Food and Drug Administration, Drug discovery, AZT, 3′-azido-3′-deoxy-thymidine (common name, zidovudine), IAS-USA, International Antiviral Society-USA, BIC, bictegravir, HIV, human immunodeficiency virus, Clinical Practice, NRTI, nucleoside/nucleotide reverse transcriptase inhibitor, NRTI, DOR, doravirine, Rilpivirine, EC50, half maximal effective concentration, DPV, dapivirine, medicine.medical_specialty, EACS, European AIDS Clinical Society, DRV, darunavir, Tenofovir alafenamide, TAF, tenofovir alafenamide, FTC, (−)-2′,3′-dideoxy-5-fluoro-3′-thiacytidine (common name, emtricitabine), Internal medicine, medicine, HIV treatment, COBI, cobicistat, TDF, tenofovir disoproxil fumarate, CAB, cabotegravir, business.industry, HAART, highly active antiretroviral therapy, Clinical efficacy, Reverse transcriptase, EVG, elvitegravir, chemistry, ATV, atazanavir, DTG, dolutegravir, business
وصف الملف: Print-Electronic